Heparin Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast period 2019-2025. The Global Heparin Industry Report gives an elaborate information about the market size, share and analyzes the complete value chain the report also covers the market dynamics enriching business strategists with quality data about the Heparin market.
This study categorizes the global Heparin breakdown data by manufacturers, region, type and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis.
Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine
Heparin API is an anticoagulant (blood thinner) that prevents the formation of blood clots. With the accelerated pace of life and increasing aging population, global morbidity and mortality of cardiovascular and cerebrovascular disease are increased year by year. Heparin API is an efficient solution to those diseases.
Raw materials of Heparin API are mainly porcine intestine, bovine lung and bovine intestine, etc. China pig slaughter amount accounted for more than 50% of the world. It has most abundant raw material resources all over the world.
The classification of Heparin includes Heparin Sodium, Heparin Calcium and others, and the proportion of Heparin Sodium in 2016 is about 88%, and the proportion is in decreasing trend from 2012 to 2016.
Heparin is widely used UFH and LMWH. The most proportion of Heparin is used in LMWH, and the proportion in 2016 is 88.9%
Europe is the largest consumption place, with a consumption market share nearly 40% in 2016. Following Europe, United Stated is the second largest consumption place with the consumption market share of 36%.
Market competition is not intense. Hepalink, Bioibérica, Changshan Pharm, etc. are the leaders of the industry, with high-end customers; have been formed in the monopoly position in the industry.
Global Heparin market size will increase to 1290 Million US$ by 2025, from 990 Million US$ in 2017, at a CAGR of 3.4% during the forecast period. In this study, 2017 has been considered as the base year and 2018 to 2025 as the forecast period to estimate the market size for Heparin.
This report focuses on the top manufacturers' Heparin capacity, production, value, price and market share of Heparin in global market. The following manufacturers are covered in this report:
- Hepalink
- Changshan Pharm
- Qianhong Bio-pharma
- Opocrin
- Pfizer
- Aspen Oss
- King-friend Biochemical Pharmaceutical
- Bioibérica
- Dongcheng Biochemicals
- Jiulong Biochemicals
- Tiandong
- Xinbai
- Yino Pharma Limited
- Deebio
Heparin Breakdown Data by Type
- Heparin Sodium
- Heparin Calcium
- Other
Heparin Breakdown Data by Application
Heparin Production Breakdown Data by Region
- United States
- Europe
- China
- Japan
- Other Regions
Heparin Consumption Breakdown Data by Region
- North America
- United States
- Canada
- Mexico
- Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Malaysia
- Philippines
- Thailand
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Rest of Europe
- Central & South America
- Brazil
- Rest of South America
- Middle East & Africa
- GCC Countries
- Turkey
- Egypt
- South Africa
- Rest of Middle East & Africa
The study objectives are:
- To analyze and research the global Heparin capacity, production, value, consumption, status and forecast;
- To focus on the key Heparin manufacturers and study the capacity, production, value, market share and development plans in next few years.
- To focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
- To define, describe and forecast the market by type, application and region.
- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
- To identify significant trends and factors driving or inhibiting the market growth.
- To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
- To strategically analyze each submarket with respect to individual growth trend and their contribution to the market.
- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
- To strategically profile the key players and comprehensively analyze their growth strategies.